Chaired by Hiroyoshi Nishikawa, MD, PhD, and Charles Swanton, MD, PhD, FAACR, this joint collaboration with the Japanese Cancer Association (JCA) showcased the latest developments in precision cancer medicine. Launched in 2022 and reprised in 2023, the conference will be held in Japan every two to three years going forward.